Daily Movers for October 22th, 2019Biogen Inc. (NASDAQ: BIIB) shares surged by over 35% on Tuesday morning after the Company announced it will seek U.S. FDA approval for its Alzheimer’s drug, aducanumab. Aducanumab is an investigational human ...

What's Buzzing